COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
0 hedge funds and large institutions have $0 invested in COSCIENS Biopharma Inc. Common Stock in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0.12% less ownership
Funds ownership: 0.12% → 0% (-0.12%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $10.3K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$10.2K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$153 |
CSCI Hedge Fund Activity: Q4 2025 in Review
0 of the 8,288 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2025, worth a combined $0 — down 100% from $10.3K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CSCI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was TD Waterhouse Canada, exiting entirely with an estimated $10.2K sold.
- 0 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2025, down from 2 in Q3 2025.
- Funds reported $0 of COSCIENS Biopharma Inc. Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2025 and 2 closed out, a net change of -2 holders.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2025 was TD Waterhouse Canada, an estimated $10.2K sold.
Based on aggregated 13F filings for Q4 2025.